Abstract
Hypercalcaemia is found in about 1% of all hospitalised patients and caused by malignancy in 46% of all cases and by pHPT in 35%. In the remaining 19%, other conditions are responsible. These include sarcoidosis, immobilisation and medications such as thiazides or active metabolites of vitamin D. Patients with mild hypercalcaemia have no symptoms. The term “hypercalcaemic syndrome” refers to a constellation of symptoms independent of the aetiology including renal, gastrointestinal and neuropsychiatric changes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bartl, R., Bartl, C. (2019). Tumour-Induced Hypercalcaemia (TIH). In: The Osteoporosis Manual. Springer, Cham. https://doi.org/10.1007/978-3-030-00731-7_78
Download citation
DOI: https://doi.org/10.1007/978-3-030-00731-7_78
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-00730-0
Online ISBN: 978-3-030-00731-7
eBook Packages: MedicineMedicine (R0)